Skip to main content
Top
Published in: Head and Neck Pathology 1/2015

01-03-2015 | Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, March 22, 2015, Boston, Massachusetts

IgG4 Related Disease of the Head and Neck

Author: Vikram Deshpande

Published in: Head and Neck Pathology | Issue 1/2015

Login to get access

Abstract

IgG4 related disease of the head and neck region represents one of the more common manifestations of IgG4 related disease. Involvement of the submandibular and parotid glands, the orbit and thyroid represent some of the more common sites involved by IgG4 related disease. Eosinophilic angiocentric fibrosis, Mikulicz disease and Riedel thyroiditis are also members of the family of IgG4 related disease. Clinically, the disease is characterized by tumefactive lesions, often multicentric, that show a swift response to immunosuppressive therapy. An elevated serum IgG4 represents the only validated blood based biomarker. However, elevated serum IgG4 is detected in only half the patients with this disease. Histology continues to represent the gold standard for the diagnosis of IgG4 related disease: storiform-type fibrosis and obliterative phlebitis constitute characteristic features of this disease. A definitive diagnosis of IgG4 related disease also requires the presence of elevated numbers of IgG4 positive plasma cells as well as an IgG4 to IgG ratio of greater than 40 %. In isolation, elevated numbers of IgG4 positive plasma cells represents a non-specific feature, detected in a variety of other inflammatory as well as neoplastic diseases. Attention to the clinical context, histological features, as well as an elevated IgG4 to IgG ratio is critical to avoiding overdiagnosis of IgG4 related disease.
Literature
1.
2.
go back to reference Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.CrossRefPubMed Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.CrossRefPubMed
3.
go back to reference Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25:1086–97.CrossRefPubMed Li Y, Zhou G, Ozaki T, et al. Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol. 2012;25:1086–97.CrossRefPubMed
4.
go back to reference Deshpande V, Huck A, Ooi E, et al. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012;65:725–8.CrossRefPubMed Deshpande V, Huck A, Ooi E, et al. Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol. 2012;65:725–8.CrossRefPubMed
6.
go back to reference Della-Torre E, Mattoo H, Mahajan VS, et al. IgG4-related midline destructive lesion. Ann Rheum Dis. 2014;73:1434–6.CrossRefPubMed Della-Torre E, Mattoo H, Mahajan VS, et al. IgG4-related midline destructive lesion. Ann Rheum Dis. 2014;73:1434–6.CrossRefPubMed
7.
go back to reference Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol. 2012;29:177–90.CrossRefPubMed Stone JH. IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol. 2012;29:177–90.CrossRefPubMed
8.
go back to reference Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191–6.CrossRefPubMed Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29:191–6.CrossRefPubMed
9.
go back to reference Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–87.CrossRefPubMed Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679–87.CrossRefPubMed
10.
go back to reference Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–5.CrossRefPubMed Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190–5.CrossRefPubMed
12.
go back to reference Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235–44.CrossRefPubMed Ferry JA, Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol. 2012;29:235–44.CrossRefPubMed
13.
go back to reference Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812–9.CrossRefPubMed Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812–9.CrossRefPubMed
14.
go back to reference Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol. 2005;29:783–91.CrossRefPubMed Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner’s tumor). Am J Surg Pathol. 2005;29:783–91.CrossRefPubMed
15.
16.
go back to reference Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202–10.CrossRefPubMed Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34:202–10.CrossRefPubMed
17.
go back to reference Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMed Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMed
18.
go back to reference Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.CrossRefPubMed Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.CrossRefPubMed
19.
20.
go back to reference Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.CrossRefPubMedCentralPubMed Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335–40.CrossRefPubMedCentralPubMed
21.
go back to reference Deshpande V, Khosroshahi A, Nielsen GP, et al. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701–6.CrossRefPubMed Deshpande V, Khosroshahi A, Nielsen GP, et al. Eosinophilic angiocentric fibrosis is a form of IgG4-related systemic disease. Am J Surg Pathol. 2011;35:701–6.CrossRefPubMed
22.
go back to reference Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.CrossRefPubMed Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.CrossRefPubMed
23.
go back to reference Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocr J. 2012;59:273–81.CrossRefPubMed Kakudo K, Li Y, Taniguchi E, et al. IgG4-related disease of the thyroid glands. Endocr J. 2012;59:273–81.CrossRefPubMed
24.
go back to reference Li Y, Nishihara E, Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102–7.CrossRefPubMed Li Y, Nishihara E, Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23:102–7.CrossRefPubMed
25.
go back to reference Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int. 2011;61:175–83.CrossRefPubMed Kakudo K, Li Y, Hirokawa M, et al. Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int. 2011;61:175–83.CrossRefPubMed
26.
go back to reference Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309–17.CrossRefPubMed Li Y, Nishihara E, Hirokawa M, et al. Distinct clinical, serological, and sonographic characteristics of hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab. 2010;95:1309–17.CrossRefPubMed
27.
28.
go back to reference Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRef Dahlgren M, Khosroshahi A, Nielsen GP, et al. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken). 2010;62:1312–8.CrossRef
29.
go back to reference Bartholomew LG, Cain JC, Woolner LB, et al. Sclerosing cholangitis: its possible association with Riedel’s struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963;269:8–12.CrossRefPubMed Bartholomew LG, Cain JC, Woolner LB, et al. Sclerosing cholangitis: its possible association with Riedel’s struma and fibrous retroperitonitis. Report of two cases. N Engl J Med. 1963;269:8–12.CrossRefPubMed
30.
go back to reference Reder L, Della-Torre E, Stone JH, et al. Clinical manifestations of IgG4-related disease in the pharynx: case series and review of the literature. Ann Otol Rhinol Laryngol. 2014;0003489414549574. Reder L, Della-Torre E, Stone JH, et al. Clinical manifestations of IgG4-related disease in the pharynx: case series and review of the literature. Ann Otol Rhinol Laryngol. 2014;0003489414549574.
31.
go back to reference Kobraei EM, Song TH, Mathisen DJ, et al. Immunoglobulin g4-related disease presenting as an obstructing tracheal mass: consideration of surgical indications. Ann Thorac Surg. 2013;96:e91–3.CrossRefPubMed Kobraei EM, Song TH, Mathisen DJ, et al. Immunoglobulin g4-related disease presenting as an obstructing tracheal mass: consideration of surgical indications. Ann Thorac Surg. 2013;96:e91–3.CrossRefPubMed
Metadata
Title
IgG4 Related Disease of the Head and Neck
Author
Vikram Deshpande
Publication date
01-03-2015
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2015
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-015-0620-6

Other articles of this Issue 1/2015

Head and Neck Pathology 1/2015 Go to the issue